ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 110 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,175 | -76.0% | 19,713 | -73.9% | 0.00% | – |
| Q2 2023 | $121,780 | -83.7% | 75,640 | -70.7% | 0.00% | -100.0% |
| Q1 2023 | $747,927 | +112.8% | 257,906 | +140.7% | 0.00% | 0.0% |
| Q4 2022 | $351,482 | -100.0% | 107,159 | -46.0% | 0.00% | 0.0% |
| Q3 2022 | $749,449,000 | +257.8% | 198,267 | +637.5% | 0.00% | – |
| Q2 2022 | $209,434,000 | +69.0% | 26,885 | +101.6% | 0.00% | – |
| Q1 2022 | $123,910,000 | -84.0% | 13,338 | -72.9% | 0.00% | -100.0% |
| Q4 2021 | $775,345,000 | +48.9% | 49,197 | +69.1% | 0.00% | 0.0% |
| Q3 2021 | $520,800,000 | +58.1% | 29,095 | +37.4% | 0.00% | – |
| Q2 2021 | $329,318,000 | -36.4% | 21,178 | -41.2% | 0.00% | -100.0% |
| Q1 2021 | $517,534,000 | -75.2% | 36,040 | -66.1% | 0.00% | -75.0% |
| Q4 2020 | $2,085,511,000 | +839.3% | 106,241 | +520.2% | 0.00% | – |
| Q3 2020 | $222,018,000 | +92.3% | 17,131 | +116.2% | 0.00% | – |
| Q2 2020 | $115,467,000 | -50.8% | 7,925 | -71.2% | 0.00% | – |
| Q1 2020 | $234,476,000 | +122.3% | 27,553 | +330.3% | 0.00% | – |
| Q4 2019 | $105,457,000 | -6.7% | 6,403 | -20.0% | 0.00% | – |
| Q3 2019 | $113,059,000 | +11.4% | 8,007 | +58.6% | 0.00% | – |
| Q2 2019 | $101,515,000 | -72.0% | 5,048 | -44.6% | 0.00% | -100.0% |
| Q1 2019 | $362,321,000 | +2703.7% | 9,115 | +2350.3% | 0.00% | – |
| Q4 2018 | $12,923,000 | -81.3% | 372 | -77.8% | 0.00% | – |
| Q3 2018 | $69,220,000 | +19.3% | 1,674 | +6.0% | 0.00% | – |
| Q2 2018 | $58,028,000 | -78.0% | 1,579 | -76.7% | 0.00% | – |
| Q1 2018 | $264,225,000 | +155.6% | 6,775 | +18.6% | 0.00% | – |
| Q4 2017 | $103,369,000 | +155.8% | 5,711 | +133.9% | 0.00% | – |
| Q3 2017 | $40,415,000 | +10.9% | 2,442 | -6.1% | 0.00% | – |
| Q2 2017 | $36,428,000 | +1242.7% | 2,602 | +1871.2% | 0.00% | – |
| Q1 2017 | $2,713,000 | -85.3% | 132 | -89.9% | 0.00% | – |
| Q4 2016 | $18,488,000 | -46.2% | 1,302 | -18.9% | 0.00% | – |
| Q3 2016 | $34,352,000 | +62.9% | 1,606 | +71.4% | 0.00% | – |
| Q2 2016 | $21,092,000 | -79.4% | 937 | -75.9% | 0.00% | – |
| Q4 2015 | $102,576,000 | -7.5% | 3,884 | +10.1% | 0.00% | – |
| Q3 2015 | $110,952,000 | +74.5% | 3,529 | +192.9% | 0.00% | – |
| Q2 2015 | $63,576,000 | +849.9% | 1,205 | +648.4% | 0.00% | – |
| Q1 2015 | $6,693,000 | – | 161 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XV Associates, LLC | 1,876,650 | $29,182,000 | 13.03% |
| Copernicus Capital Management, LLC | 50,000 | $778,000 | 12.27% |
| Antipodean Advisors LLC | 1,000,000 | $15,550,000 | 4.28% |
| BRIDGER MANAGEMENT, LLC | 1,325,188 | $20,607,000 | 1.92% |
| Redmile Group, LLC | 6,449,577 | $100,291,000 | 1.48% |
| MAVERICK CAPITAL LTD | 7,704,676 | $119,808,000 | 1.12% |
| Baupost Group | 8,477,488 | $131,825,000 | 1.07% |
| ACT CAPITAL MANAGEMENT, LLC | 116,900 | $1,818,000 | 0.93% |
| Trellus Management Company, LLC | 73,056 | $1,136,000 | 0.78% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $8,164,000 | 0.75% |